Timken Board Approves New $1.05 Billion Share Repurchase Program
TKR sits 88% above its 52-week low of $56.2.
Summary
Timken's Board approved a new share repurchase plan authorizing the buyback of up to ten million common shares, valued at over $1 billion.
Key Events · Financing and Capital Events · TKR
-
New Share Repurchase Plan Approved
The Board of Directors approved a new share purchase plan, effective March 1, 2026, authorizing the repurchase of up to ten million common shares.
-
Substantial Capital Allocation
The plan represents a significant commitment to returning capital to shareholders, with a potential value exceeding $1 billion based on current share prices.
-
Replaces Prior Program
This new program replaces the previous share purchase plan, which is set to expire on February 28, 2026, ensuring continuity in capital management.
Analysis · TKR · Technology
The Timken Company's Board of Directors has approved a new share purchase plan, authorizing the repurchase of up to ten million common shares. This program, effective March 1, 2026, represents a substantial capital allocation decision, with a potential value exceeding $1 billion based on the current stock price. Such a significant repurchase plan, representing over 14% of the company's market capitalization, typically signals strong management confidence in the company's valuation and commitment to enhancing shareholder value. This new plan replaces a prior program, ensuring continuity in the company's capital management strategy.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.5% of the 1055 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TKR was trading at $105.54 on NYSE in the Technology sector, with a market capitalization of approximately $7.4B. The 52-week trading range was $56.20 to $111.39. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.